Avenue Therapeutics, Inc.

BST:49Y0 Stock Report

Market Cap: €3.4m

Avenue Therapeutics Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Alix MacLean

Chief executive officer

US$1.2m

Total compensation

CEO salary percentage33.0%
CEO tenure1.7yrs
CEO ownershipn/a
Management average tenure2.1yrs
Board average tenure5.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Alix MacLean's remuneration changed compared to Avenue Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$1mUS$400k

-US$10m

Sep 30 2023n/an/a

-US$10m

Jun 30 2023n/an/a

-US$12m

Mar 31 2023n/an/a

-US$8m

Dec 31 2022US$516kUS$154k

-US$4m

Compensation vs Market: Alix's total compensation ($USD1.21M) is above average for companies of similar size in the German market ($USD401.52K).

Compensation vs Earnings: Alix's compensation has increased whilst the company is unprofitable.


CEO

Alix MacLean (55 yo)

1.7yrs

Tenure

US$1,213,200

Compensation

Dr. Alexandra MacLean, also known as Alix, MD, serves as Director of Kent Imaging Inc. since January 2021. She is Chief Executive Officer at Avenue Therapeutics, Inc. since August 01, 2022 and serves as it...


Leadership Team

NamePositionTenureCompensationOwnership
Alexandra MacLean
CEO & Director1.7yrsUS$1.21mno data
David Jin
Interim CFO2.1yrsUS$260.00k0%
€ 0
Lindsay Rosenwald
Executive Director1.1yrsUS$104.00k0.79%
€ 27.1k
Xiaoqin Lu
Consultant2.1yrsUS$1.05mno data
Scott Reines
Interim Chief Medical Officer8.3yrsUS$123.12kno data
Srinivas Subramanian
Executive Vice Presidentno datano datano data

2.1yrs

Average Tenure

53.5yo

Average Age

Experienced Management: 49Y0's management team is considered experienced (2.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Alexandra MacLean
CEO & Director1.1yrsUS$1.21mno data
Lindsay Rosenwald
Executive Director9.2yrsUS$104.00k0.79%
€ 27.1k
Jay Kranzler
Chairman of the Board7.2yrsUS$212.19k0.020%
€ 689.5
Neil Herskowitz
Non-Executive Independent Director8.7yrsUS$60.00k0.020%
€ 689.5
Faith Charles
Independent Director1.9yrsUS$154.00k0%
€ 0
Curtis Oltmans
Independent Director3yrsUS$154.00k0.0075%
€ 255.2

5.1yrs

Average Tenure

64yo

Average Age

Experienced Board: 49Y0's board of directors are considered experienced (5.1 years average tenure).